Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ASTRAZENECA PHARMA PFIZER/
ASTRAZENECA PHARMA
 
P/E (TTM) x 38.2 94.6 40.4% View Chart
P/BV x 6.0 22.5 26.6% View Chart
Dividend Yield % 1.7 0.3 550.1%  

Financials

 PFIZER   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-23
ASTRAZENECA PHARMA
Mar-23
PFIZER/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6623,620 128.8%   
Low Rs3,4072,438 139.8%   
Sales per share (Unadj.) Rs530.0401.2 132.1%  
Earnings per share (Unadj.) Rs136.439.7 343.4%  
Cash flow per share (Unadj.) Rs159.446.2 345.0%  
Dividends per share (Unadj.) Rs70.0016.00 437.5%  
Avg Dividend yield %1.70.5 328.4%  
Book value per share (Unadj.) Rs701.0234.4 299.0%  
Shares outstanding (eoy) m45.7525.00 183.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.67.5 100.8%   
Avg P/E ratio x29.676.3 38.8%  
P/CF ratio (eoy) x25.365.5 38.6%  
Price / Book Value ratio x5.812.9 44.5%  
Dividend payout %51.340.3 127.4%   
Avg Mkt Cap Rs m184,57675,718 243.8%   
No. of employees `000NANA-   
Total wages/salary Rs m3,3172,591 128.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,24810,030 241.8%  
Other income Rs m1,011261 387.2%   
Total revenues Rs m25,25810,291 245.4%   
Gross profit Rs m8,4201,249 674.2%  
Depreciation Rs m1,055163 648.9%   
Interest Rs m1356 2,139.7%   
Profit before tax Rs m8,2401,341 614.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,001348 574.8%   
Profit after tax Rs m6,239993 628.4%  
Gross profit margin %34.712.5 278.9%  
Effective tax rate %24.326.0 93.5%   
Net profit margin %25.79.9 259.9%  
BALANCE SHEET DATA
Current assets Rs m24,9339,359 266.4%   
Current liabilities Rs m6,5744,844 135.7%   
Net working cap to sales %75.745.0 168.2%  
Current ratio x3.81.9 196.3%  
Inventory Days Days9349 188.9%  
Debtors Days Days239 5.8%  
Net fixed assets Rs m13,7802,061 668.5%   
Share capital Rs m45850 915.0%   
"Free" reserves Rs m31,6165,811 544.0%   
Net worth Rs m32,0735,861 547.2%   
Long term debt Rs m00-   
Total assets Rs m39,03111,421 341.8%  
Interest coverage x62.1213.9 29.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 70.7%   
Return on assets %16.38.7 186.7%  
Return on equity %19.516.9 114.8%  
Return on capital %26.123.0 113.6%  
Exports to sales %2.80-   
Imports to sales %037.4 0.1%   
Exports (fob) Rs m688NA-   
Imports (cif) Rs m83,747 0.2%   
Fx inflow Rs m688612 112.4%   
Fx outflow Rs m83,747 0.2%   
Net fx Rs m679-3,135 -21.7%   
CASH FLOW
From Operations Rs m3,557583 610.2%  
From Investments Rs m-361181 -199.1%  
From Financial Activity Rs m-3,458-245 1,412.5%  
Net Cashflow Rs m-262519 -50.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 18.2 5.4 335.4%  
FIIs % 3.0 2.7 113.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 25.0 144.3%  
Shareholders   112,456 29,032 387.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Pfizer vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs ASTRAZENECA PHARMA Share Price Performance

Period Pfizer ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day -4.83% -0.92% 1.18%
1-Month -8.27% -4.51% -0.75%
1-Year 21.74% 57.72% 61.82%
3-Year CAGR -2.08% 20.13% 18.16%
5-Year CAGR 4.94% 21.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of Pfizer, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.